Leukotriene F4
Leukotriene F4 (LTF4), is a lipid that belongs to the Cysteinyl Leukotriene (CysTL) family[1]. Leukotriene F4 induces bronchoconstriction with an ED50 of 16 μg/kg[2]. The precursor of LTF4 is Leukotriene E4 (LTE4), which isformed from the action of a glutamyl transferase[1].
Product Specifications
CAS Number
[83851-42-7]
UNSPSC
12352211
Hazard Statement
H225-H301+H311+H331-H370
Target
Endogenous Metabolite; Leukotriene Receptor
Type
Reference compound
Related Pathways
GPCR/G Protein; Metabolic Enzyme/Protease
Applications
Metabolism-protein/nucleotide metabolism
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/leukotriene-f4.html
Solubility
10 mM in DMSO
Smiles
O=C(O)[C@H](CS[C@@H]([C@@H](O)CCCC(O)=O)/C=C/C=C/C=C\C/C=C\CCCCC)NC(CC[C@@H](C(O)=O)N)=O
Molecular Formula
C28H44N2O8S
Molecular Weight
568.72
Precautions
References & Citations
[1]Reddanna P, et al. Carboxypeptidase A-catalyzed direct conversion of leukotriene C4 to leukotriene F4. Arch Biochem Biophys. 2003;413 (2) :158-163.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
Human Endogenous Metabolite
Explore Other Products
Browse additional items from our catalog
Ctu2 Mouse shRNA Lentiviral Particle (Locus ID 66965)
CSE1L/CAS/Exportin-2 Recombinant Protein Antigen